132 related articles for article (PubMed ID: 1996578)
1. Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition.
Praga M; Borstein B; Andres A; Arenas J; Oliet A; Montoyo C; Ruilope LM; Rodicio JL
Am J Kidney Dis; 1991 Mar; 17(3):330-8. PubMed ID: 1996578
[TBL] [Abstract][Full Text] [Related]
2. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria.
Praga M; Hernández E; Montoyo C; Andrés A; Ruilope LM; Rodicio JL
Am J Kidney Dis; 1992 Sep; 20(3):240-8. PubMed ID: 1519604
[TBL] [Abstract][Full Text] [Related]
3. Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration.
Praga M; Morales E; Herrero JC; Pérez Campos A; Domínguez-Gil B; Alegre R; Vara J; Martínez MA
Am J Kidney Dis; 1999 Jan; 33(1):52-8. PubMed ID: 9915267
[TBL] [Abstract][Full Text] [Related]
4. Antiproteinuric effect of angiotensin-converting-enzyme inhibitors in patients with primary glomerular disease and normal renal function.
Fabbri A; Cocchi R; Degli Esposti E; Lucatello A; Sturani A; Tampieri G; Fusaroli M
Nephrol Dial Transplant; 1990; 5 Suppl 1():81-3. PubMed ID: 2129469
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of captopril treatment in children with steroid-resistant nephrotic syndrome.
Sözüer DT; Emre S; Tanman F; Sirin A; Nayir A; Uysal V
Acta Paediatr Jpn; 1994 Dec; 36(6):658-61. PubMed ID: 7871977
[TBL] [Abstract][Full Text] [Related]
6. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
[TBL] [Abstract][Full Text] [Related]
7. Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.
Wilmer WA; Hebert LA; Lewis EJ; Rohde RD; Whittier F; Cattran D; Levey AS; Lewis JB; Spitalewitz S; Blumenthal S; Bain RP
Am J Kidney Dis; 1999 Aug; 34(2):308-14. PubMed ID: 10430979
[TBL] [Abstract][Full Text] [Related]
8. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment.
Rostoker G; Ben Maadi A; Remy P; Lang P; Lagrue G; Weil B
Nephrol Dial Transplant; 1995; 10(1):25-9. PubMed ID: 7724024
[TBL] [Abstract][Full Text] [Related]
9. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
Nakhoul F; Ramadan R; Khankin E; Yaccob A; Kositch Z; Lewin M; Assady S; Abassi Z
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
[TBL] [Abstract][Full Text] [Related]
10. The progression of adriamycin-induced nephrotic syndrome in rats and the effect of captopril.
Hall RL; Wilke WL; Fettman MJ
Toxicol Appl Pharmacol; 1986 Jan; 82(1):164-74. PubMed ID: 3511565
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
Huh H; Lee H; Lee JP; Kim DK; Oh S; Oh YK; Kim YS; Lim CS
BMC Nephrol; 2017 Mar; 18(1):104. PubMed ID: 28347297
[TBL] [Abstract][Full Text] [Related]
12. Antiproteinuric effect of angiotensin-converting enzyme inhibition and C5b-9 urinary excretion in membranous glomerulonephritis.
Praga M; Paz Artal E; Hernández E; Segura J; Moreno MA; Morales JM; Rodicio JL
Nephrol Dial Transplant; 1997 Dec; 12(12):2576-9. PubMed ID: 9430854
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome.
Milliner DS; Morgenstern BZ
Pediatr Nephrol; 1991 Sep; 5(5):587-90. PubMed ID: 1911144
[TBL] [Abstract][Full Text] [Related]
14. Renal effects of captopril, indomethacin and nifedipine in nephrotic patients after an oral protein load.
Garini G; Mazzi A; Buzio C; Mutti A; Allegri L; Savazzi G; Borghetti A
Nephrol Dial Transplant; 1996 Apr; 11(4):628-34. PubMed ID: 8671850
[TBL] [Abstract][Full Text] [Related]
15. Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome.
Shapira Y; Mor F; Friedler A; Wysenbeek AJ; Weinberger A
Ann Rheum Dis; 1990 Sep; 49(9):725-7. PubMed ID: 2241292
[TBL] [Abstract][Full Text] [Related]
16. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
[TBL] [Abstract][Full Text] [Related]
17. Effect of the angiotensin converting enzyme inhibitor, captopril, on proteinuria in chronic glomerular disease.
Masunaga Y; Tabei K; Takeda S; Ando Y; Kusano E; Asano Y
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):961-6. PubMed ID: 8255007
[TBL] [Abstract][Full Text] [Related]
18. Remission of nephrotic range proteinuria in type I diabetes. Collaborative Study Group.
Hebert LA; Bain RP; Verme D; Cattran D; Whittier FC; Tolchin N; Rohde RD; Lewis EJ
Kidney Int; 1994 Dec; 46(6):1688-93. PubMed ID: 7700028
[TBL] [Abstract][Full Text] [Related]
19. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
Kosmadakis G; Filiopoulos V; Georgoulias C; Tentolouris N; Michail S
Scand J Urol Nephrol; 2010 Sep; 44(4):251-6. PubMed ID: 20201749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
